NYSE:TEVA   Teva Pharmaceutical Industries Limited
TEVA’s innovation outlook is neutral based on a current score of 56 out of 99, outperforming sector average. Insiders sentiment is positive. TEVA is an Average Performer in terms of sustainability. Over the past 4 quarters TEVA beat earnings estimates 3 times.
For more analysis and articles visit our website.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。